Synaptic dysfunction and loss due to the accumulation of tau in synapses and subsequent trans-synaptic propagation of tau pathology underlines the importance of designing synaptic therapy approaches to preserve synapses and halt the spread of tauopathy and memory decline in AD. This evidence concerns the gene MAPT and Alzheimer disease.